L. Timmerman

707 total citations
26 papers, 565 citations indexed

About

L. Timmerman is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, L. Timmerman has authored 26 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in L. Timmerman's work include Treatment of Major Depression (8 papers), Bipolar Disorder and Treatment (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). L. Timmerman is often cited by papers focused on Treatment of Major Depression (8 papers), Bipolar Disorder and Treatment (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). L. Timmerman collaborates with scholars based in Netherlands, Denmark and Belgium. L. Timmerman's co-authors include C.M.E. Kremer, Myriam Van Moffaert, Marc Ansseau, Søren Korsgaard, J Guelfi, Durk Fekkes, C.A.L. Hoogduin, L. Pepplinkhuizen, P.M.J. Haffmans and H. E. Høpfner Petersen and has published in prestigious journals such as Psychopharmacology, The Journal of Clinical Psychiatry and Journal of Clinical Psychopharmacology.

In The Last Decade

L. Timmerman

24 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Timmerman Netherlands 10 378 303 142 97 96 26 565
Angelo Sambunaris United States 10 324 0.9× 200 0.7× 140 1.0× 81 0.8× 54 0.6× 15 436
Trisha L. Houser United States 8 424 1.1× 406 1.3× 236 1.7× 84 0.9× 45 0.5× 13 666
Quynh-Van Tran United States 16 311 0.8× 448 1.5× 104 0.7× 96 1.0× 37 0.4× 20 689
Karl Burgoyne United States 12 257 0.7× 368 1.2× 104 0.7× 64 0.7× 61 0.6× 20 717
Charles Merideth United States 10 234 0.6× 335 1.1× 195 1.4× 49 0.5× 104 1.1× 11 607
Kelly Schwartz United States 8 172 0.5× 324 1.1× 89 0.6× 78 0.8× 124 1.3× 8 674
J O Cole United States 8 350 0.9× 353 1.2× 147 1.0× 57 0.6× 89 0.9× 10 583
Marianne Dragheim Denmark 7 412 1.1× 154 0.5× 221 1.6× 159 1.6× 53 0.6× 11 507
P. Tanghøj Denmark 11 313 0.8× 285 0.9× 156 1.1× 69 0.7× 55 0.6× 18 653
Simon Patry Canada 10 419 1.1× 448 1.5× 90 0.6× 136 1.4× 67 0.7× 19 887

Countries citing papers authored by L. Timmerman

Since Specialization
Citations

This map shows the geographic impact of L. Timmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Timmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Timmerman more than expected).

Fields of papers citing papers by L. Timmerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Timmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Timmerman. The network helps show where L. Timmerman may publish in the future.

Co-authorship network of co-authors of L. Timmerman

This figure shows the co-authorship network connecting the top 25 collaborators of L. Timmerman. A scholar is included among the top collaborators of L. Timmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Timmerman. L. Timmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timmerman, L., et al.. (2013). 455 – Antibiomania, Acute Manic Psychosis Following the Use of Antibiotics. European Psychiatry. 28(S1).
2.
Timmerman, L., et al.. (2012). A review of modafinil and armodafinil as add-on therapy in antipsychotic-treated patients with schizophrenia. Therapeutic Advances in Psychopharmacology. 2(3). 115–125. 19 indexed citations
3.
Timmerman, L., et al.. (2011). [Neurosyphilis: unexpected reunion with an old acquaintance].. PubMed. 53(2). 125–9. 3 indexed citations
4.
Kamphuis, Helen, et al.. (2010). [Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].. PubMed. 52(4). 223–33. 7 indexed citations
5.
Timmerman, L., et al.. (2006). [Galactorrhoea and the use of selective serotonin reuptake inhibitors].. PubMed. 48(3). 229–34. 2 indexed citations
6.
Klumpers, Ursula M. H., L. Timmerman, A.J.M. Loonen, et al.. (2004). Responsivity to Stress in Chronic Posttraumatic Stress Disorder Due to Childhood Sexual Abuse. Psychological Reports. 94(2). 408–410. 11 indexed citations
7.
Wessels, Alette M., et al.. (2004). Remission of positive symptomatology of a schizophrenic psychosis after withdrawing lamotrigine: a case report. European Psychiatry. 19(1). 59–61. 2 indexed citations
8.
Timmerman, L.. (2003). Panic disorder and depression: relationship between psychological and biochemical aspects. Acta Neuropsychiatrica. 15(1). 26–31. 1 indexed citations
9.
Guelfi, J, Marc Ansseau, L. Timmerman, & Søren Korsgaard. (2001). Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features. Journal of Clinical Psychopharmacology. 21(4). 425–431. 102 indexed citations
10.
Guelfi, J.D., et al.. (2000). Efficacy and tolerability of mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholia. European Neuropsychopharmacology. 10. 266–266. 1 indexed citations
11.
Timmerman, L., et al.. (1998). Efficacy and tolerability of mirtazapine in everyday clinical practice in The Netherlands. European Neuropsychopharmacology. 8. S147–S147. 1 indexed citations
12.
Fekkes, Durk, L. Timmerman, & L. Pepplinkhuizen. (1997). Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression. European Neuropsychopharmacology. 7(3). 235–239. 28 indexed citations
13.
Timmerman, L., et al.. (1997). Trait Anxiety, Coping with Stress, and Norharman. Psychological Reports. 80(1). 51–59. 4 indexed citations
14.
Haffmans, P.M.J., L. Timmerman, & C.A.L. Hoogduin. (1996). Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients. International Clinical Psychopharmacology. 11(3). 157–164. 41 indexed citations
15.
Pepplinkhuizen, L., Durk Fekkes, & L. Timmerman. (1996). Norharman and anxiety disorders. Acta Neuropsychiatrica. 8(4). 93–95. 7 indexed citations
16.
Fekkes, Durk, et al.. (1996). Norharman in multiple drug-addicts and healthy controls. European Neuropsychopharmacology. 6. S4–129. 2 indexed citations
17.
Timmerman, L.. (1994). Biological aspects of panic disorder. Acta Neuropsychiatrica. 6(1). 6–11. 1 indexed citations
18.
Timmerman, L., Ruth Verhey, & Durk Fekkes. (1994). Norharman and platelet serotonin in panic disorder patients compared with healthy controls. European Neuropsychopharmacology. 4(3). 353–354. 2 indexed citations
19.
Timmerman, L., et al.. (1987). A Double-Blind Comparative Clinical Trial of Citalopram vs Maprotiline in Hospitalized Depressed Patients. International Clinical Psychopharmacology. 2(3). 239–253. 32 indexed citations
20.
Møller, Svend E., et al.. (1986). Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. Psychopharmacology. 88(1). 96–100. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Sambunaris Breakdown of academic impact, for papers by Trisha L. Houser Breakdown of academic impact, for papers by Quynh-Van Tran Breakdown of academic impact, for papers by Karl Burgoyne Breakdown of academic impact, for papers by Charles Merideth Breakdown of academic impact, for papers by Kelly Schwartz Breakdown of academic impact, for papers by J O Cole Breakdown of academic impact, for papers by Marianne Dragheim Breakdown of academic impact, for papers by P. Tanghøj Breakdown of academic impact, for papers by Simon Patry
Rankless by CCL
2026